Clot-targeting Of CD39 Through Genetic Fusion To An Activated-platelet Specific Single-chain Antibody Provides Efficient Inhibition Of ADP Receptor-mediated Platelet Activation Without Systemic Platelet Inhibition.

Jan David Hohmann, Stefanie Krajewski, X Wang, Carly Selan, Andreas Straub, Harshal Hanumant Nandurkar, Christoph Eugen Hagemeyer, Karlheinz Peter

Research output: Contribution to conferenceAbstractOtherpeer-review

Original languageEnglish
PagesS21
Publication statusPublished - 2011

Cite this

@conference{95208bf2f8cb4ad48938fc82893b782c,
title = "Clot-targeting Of CD39 Through Genetic Fusion To An Activated-platelet Specific Single-chain Antibody Provides Efficient Inhibition Of ADP Receptor-mediated Platelet Activation Without Systemic Platelet Inhibition.",
author = "Hohmann, {Jan David} and Stefanie Krajewski and X Wang and Carly Selan and Andreas Straub and Nandurkar, {Harshal Hanumant} and Hagemeyer, {Christoph Eugen} and Karlheinz Peter",
year = "2011",
language = "English",
pages = "S21",

}

TY - CONF

T1 - Clot-targeting Of CD39 Through Genetic Fusion To An Activated-platelet Specific Single-chain Antibody Provides Efficient Inhibition Of ADP Receptor-mediated Platelet Activation Without Systemic Platelet Inhibition.

AU - Hohmann, Jan David

AU - Krajewski, Stefanie

AU - Wang, X

AU - Selan, Carly

AU - Straub, Andreas

AU - Nandurkar, Harshal Hanumant

AU - Hagemeyer, Christoph Eugen

AU - Peter, Karlheinz

PY - 2011

Y1 - 2011

M3 - Abstract

SP - S21

ER -